王修含醫師IMCAS國際會議演講：
英卡思國際整形美容暨皮膚抗衰老大師課程(
IMCAS,
International Master Course on Aging Skin)
本屆會議，
王修含醫師受邀將進行五場演講，並擔任座長主持三場研討會。
相關連結
http://www.imcas.com/en/profile/dr-shiou-han-wang
五場演講主題如下：
1.
Enhancing hair follicle regeneration with nonablative fractional laser (以飛梭雷射刺激毛囊生髮)
2.
Anti-aging novelty in cosmeceuticals (抗老化藥妝品新進展)
3.
Melasma treatment with multiple vascular & pigment lasers(以多種血管與色素雷射治療肝斑)
4.
Tension adjustment of tear trough ligament with fillers: a minimally invasive approach method to treat tear troughs (淚溝韌帶調整術合併注射物填充)
5.
Application of platelet-rich plasma (PRP) to treat atrophic acne scars(以PRP青春痘凹洞痘疤治療：由學術文獻探討可能機轉與作用)
主持之三場研討會主題如下：
1. The science behind lipolysis: laser, EBD & cooling
2. Updates on RF, PDT & IPL
3. Research & new technologies
【
本站文章版權所有，歡迎非商業性「
部份」轉載（請勿全文轉載），轉載請註明
作者姓名標示(
皮膚科王修含醫師)與
出處(
skin168.net/
skin168.com/
skin168.org)，禁止更動內文，並提供
有效的本站超連結。】
詳細場次與時間，請參見下列資訊：
ID Date Beginning Duration Room Session title Lecture title Specifications
41490 29 July 2016 08:40 10 min room 4 Session 06
Hair restoration Enhancing hair follicle regeneration with nonablative fractional laser ORAL PRESENTATION: present your research, technique, method or results. Videos may be included.
39557 29 July 2016 09:11 12 min room 2 Cosmeceuticals 01
Cosmeceuticals: rejuvenation & trends Anti-aging novelty in cosmeceuticals ORAL PRESENTATION: present your research, technique, method or results. Videos may be included.
45112 29 July 2016 09:30 room 1 Session 02
The science behind lipolysis: laser, EBD & cooling Chair CHAIR: moderate each speaker's presentation duration and objectivity. Note that a short introduction of the session and of yourself is required.
45820 29 July 2016 10:00 room 2 Cosmeceuticals 01
Cosmeceuticals: rejuvenation & trends Panel discussion ROUND TABLE DISCUSSION: you are taking part in a roundtable discussion on a pre-determined topic. The discussion will be led by the Chairs of the session.
41307 29 July 2016 18:24 12 min room 2 Teaching course 01
Laser & EBD treating pigmentation: practical approaches Melasma treatment with multiple vascular & pigment lasers TEACHING COURSE LECTURE: present a technique, a method, interesting clinical cases and results - a video is mandatory.
41333 30 July 2016 08:54 12 min room 1 Session 13
From anatomy to upper and mid face rejuvenation Tension adjustment of tear trough ligament with fillers: a minimally invasive approach method to treat tear troughs ORAL PRESENTATION: present your research, technique, method or results. Videos may be included.
40536 31 July 2016 09:42 12 min room 4 Session 49
Stem cells & PRP Application of platelet-rich plasma (PRP) to treat atrophic acne scars ORAL PRESENTATION: present your research, technique, method or results. Videos may be included.
45110 31 July 2016 11:00 room 2 Session 40
Updates on RF, PDT & IPL Chair CHAIR: moderate each speaker's presentation duration and objectivity. Note that a short introduction of the session and of yourself is required.
45478 31 July 2016 15:00 room 3 Session 47
Research & new technologies chair CHAIR: moderate each speaker's presentation duration and objectivity. Note that a short introduction of the session and of yourself is required.
本屆會議，
王修含醫師受邀將進行五場演講，並擔任座長主持三場研討會。
相關連結
http://www.imcas.com/en/profile/dr-shiou-han-wang
IMCAS is dedicated to teaching of the highest quality at the interface
of plastic surgery and dermatology. Our congresses take place four
times a year in wonderful locations around the world. The content of
each conference is shaped by the local aesthetic market of the host
country, thus making each of our events unique. Part of our mission is
to enable aesthetic practitioners to access great scientific content
wherever and whenever they want, which is why we have launched our
e-learning platform, IMCAS Academy, which offers to subscribers instant
access to instructional videos, scientific papers, expert interviews and
more. Come back regularly to see the latest updates!
【
本站文章版權所有，歡迎非商業性「
部份」轉載（請勿全文轉載），轉載請註明
作者姓名標示(
皮膚科王修含醫師)與
出處(
skin168.net/
skin168.com/
skin168.org)，禁止更動內文，並提供
有效的本站超連結。】
